Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/12/1011   
Active ingredient: Levoglutamide
Indication: Treatment of sickle cell disease
Sponsor: Emmaus Medical Europe Limited
The Clockhouse, Station Approach, Marlow, Bucks SL7 1NT, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/07/2012 Orphan designation EMA/OD/016/12 (2012)4765 of 04/07/2012